These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9081307)

  • 1. Enhancement of lytic enzyme production resulting from replacement of the usual morphological variant of industrial lysosubtilin producer.
    Biziulevichius GA; Normantiene T
    Lett Appl Microbiol; 1997 Feb; 24(2):133-5. PubMed ID: 9081307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysosubtilin modification, Fermosorb, designed for polymeric carrier-mediated intestinal delivery of lytic enzymes: pilot-scale preparation and evaluation of this veterinary medicinal product.
    Biziulevicius GA; Zukaite V
    Int J Pharm; 1999 Oct; 189(1):43-55. PubMed ID: 10518684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative antimicrobial activity of lysosubtilin and its acid-resistant derivative, Fermosorb.
    Biziulevièius GA; Sukaitë V
    Int J Antimicrob Agents; 2002 Jul; 20(1):65-8. PubMed ID: 12127714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lysosubtilin G10x--a new antimicrobial agent for treatment and prophylaxis. Physico-chemical properties].
    Biziuliavichius GA; Shablinskas AI; Zhukaĭte VP; Kislukhina OV
    Antibiot Med Biotekhnol; 1987 May; 32(5):331-3. PubMed ID: 3111353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of lysosubtilin per os in mice, rabbits and calves.
    Biziulevichius GA; Arestov IG
    Vet Res; 1997; 28(4):385-95. PubMed ID: 9257446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antibacterial spectrum of lisosubtilin G10X].
    Biziuliavichius GA; Shablinskas AI; Zhukaĭte VP; Kislukhina OV
    Antibiot Khimioter; 1989 Aug; 34(8):579-81. PubMed ID: 2511813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Physiological and biochemical characteristics of Bacillus subtilis variants that form amylase].
    Bakhmatova IV; Zharikova GG
    Mikrobiologiia; 1978; 47(5):893-9. PubMed ID: 101745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo studies on lysosubtilin. 3. Efficacy for treatment of mastitis and superficial lesions of the udder and teats in cows.
    Biziulevichius GA; Lukauskas K
    Vet Res; 1998; 29(5):441-56. PubMed ID: 9779557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fabrication of oral acid resistant Fermosorb (Ferment + sorbent)-type preparations can be simplified using industrial Bacillus subtilis culture filtrates as an enzyme source.
    Biziulevicius GA; Zukaite V
    Int J Pharm; 2000 Aug; 204(1-2):43-6. PubMed ID: 11011984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo studies on lysosubtilin. 2. Efficacy for treatment of post-partum endometritis in cows.
    Biziulevichius GA; Lukauskas K
    Vet Res; 1998; 29(1):47-58. PubMed ID: 9559520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relationship between morological variability of Bacillus subtilis R-623 and biosynthesis of hydrolytic enzymes].
    Bakhmatova IB; Glemzha AA; Zharikova GG
    Prikl Biokhim Mikrobiol; 1981; 17(3):415-21. PubMed ID: 6174968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of casein on induction and enhancement of production of a bacterial milk clotting protease from an indigenously isolated Bacillus subtilis.
    Dutt K; Meghwanshi GK; Gupta P; Saxena RK
    Lett Appl Microbiol; 2008 May; 46(5):513-8. PubMed ID: 18363657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Properties and localisation of mycobacillin-synthesising enzyme system in Bacillus subtilis B3.
    Sengupta S; Bose SK
    Biochim Biophys Acta; 1971 Apr; 237(1):120-2. PubMed ID: 4996109
    [No Abstract]   [Full Text] [Related]  

  • 14. [Optimization of cultivation conditions of the alpha-amylase producer Bacillus subtilis 147].
    Avdiiuk KV; Varbanets' LD
    Mikrobiol Z; 2008; 70(1):10-6. PubMed ID: 18416149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Genetic studies of a Bacillus subtilis producer of a milk-coagulating enzyme complex].
    Aleksieva Z; Shivarova N; Nikoevska Ts; Antonova T
    Acta Microbiol Bulg; 1990; 26():67-72. PubMed ID: 2129077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in the roles of a glutamine amidotransferase subunit of pyridoxal 5'-phosphate synthase between Bacillus circulans and Bacillus subtilis.
    Itagaki S; Haga M; Oikawa Y; Sakoda A; Ohke Y; Sawada H; Eguchi T; Tamegai H
    Biosci Biotechnol Biochem; 2013; 77(7):1481-5. PubMed ID: 23832367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [beta-1,3-1,4-Glucanase in spore-forming microorganisms. I. beta-Glucanase production during the growth cycle of Bacillus subtilis (Marburg Yale)].
    Borriss R
    Z Allg Mikrobiol; 1976; 16(6):475-7. PubMed ID: 824871
    [No Abstract]   [Full Text] [Related]  

  • 18. [The use of a protoplast-generating method in selecting the lytic enzyme producer Streptomyces recifensis subsp. lyticus].
    Kulikova TIa; Sten'ko AS; Bezkorovaĭnaia NK; Babenko IuS
    Antibiot Khimioter; 1994; 39(2-3):9-12. PubMed ID: 7979802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sporulation in Bacillus subtilis. Correlation of biochemical events with morphological changes in asporogenous mutants.
    Waites WM; Kay D; Dawes IW; Wood DA; Warren SC; Mandelstam J
    Biochem J; 1970 Jul; 118(4):667-76. PubMed ID: 4991477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Purification and properties of alpha-amylases in morphological variants of Bacillus subtilis].
    Bakhmatova IV; Bal'sis AB; Chiurlis TK; Glemzha AA; Ianulaĭtene KK
    Prikl Biokhim Mikrobiol; 1984; 20(6):804-9. PubMed ID: 6441162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.